Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
- PMID: 30876421
- PMCID: PMC6420735
- DOI: 10.1186/s12933-019-0841-1
Retraction Note: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
Abstract
The authors have retracted this article [1] because they have identified serious errors in their data analysis which change the conclusions of their study. All authors agree with this retraction.
Retraction of
-
Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report.Cardiovasc Diabetol. 2017 Nov 9;16(1):146. doi: 10.1186/s12933-017-0629-0. Cardiovasc Diabetol. 2017. Retraction in: Cardiovasc Diabetol. 2019 Mar 16;18(1):32. doi: 10.1186/s12933-019-0841-1. PMID: 29121934 Free PMC article. Retracted.
References
-
- Kim KM, Jung KY, Yun HM, Lee SY, Oh TJ, Jang HC, Lim S. Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report. Cardiovasc Diabetol. 2017;16:146. doi: 10.1186/s12933-017-0629-0. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
